Pharmaceuticals

Deep Vein Thrombosis Market Expansion Outlook: $1.3 Billion by 2029 Forecast

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Deep Vein Thrombosis Market Between 2025 And 2029?

The deep vein thrombosis market has experienced consistent expansion over recent years. It is projected to increase from $1.06 billion in 2024 to $1.09 billion in 2025, achieving a compound annual growth rate (CAGR) of 3.1%. Historically, this growth can be ascribed to factors such as increased vascular medicine specialization, the influence of medical guidelines, a heightened focus on thrombosis prevention, developments in clinical research, and improved diagnosis awareness.

The deep vein thrombosis market size is projected to experience consistent expansion in the coming years. Its valuation is expected to reach $1.3 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 4.4%. This projected growth during the forecast period is primarily fueled by a growing aging population, the increasing prevalence of lifestyle diseases, a greater emphasis on preventive healthcare, the emergence of innovative therapies, and a focus on patient-centric care. Significant trends anticipated in this period include increased awareness of risk factors, advancements in diagnostic techniques, innovations in treatment methods, various public health initiatives, and improved post-surgical prevention strategies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

Which Drivers Are Supporting Growth Of The Deep Vein Thrombosis Market?

The deep vein thrombosis market is expected to experience growth driven by the increasing number of individuals requiring deep vein thrombosis (DVT) treatment. DVT treatment involves managing patients suffering from deep vein thrombosis through medications such as anticoagulants and other drugs that prevent new blood clots from forming and existing clots from enlarging, thereby alleviating the disease. The growing demand for DVT treatment among patients indicates a rise in the prevalence of deep vein thrombosis, which in turn necessitates products for its diagnosis, prevention, and treatment. For example, in February 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, an overall 900,000 people could be affected each year in the United States due to deep vein thrombosis, and between 60,000 and 100,000 Americans die each year from DVT or PE (pulmonary embolism). Thus, the escalating number of individuals seeking deep vein thrombosis (DVT) treatment is a primary market driver.

What Are The Different Segment Classifications Within The Deep Vein Thrombosis Market?

The deep vein thrombosis market covered in this report is segmented –

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class

2) By Treatment: Surgery, Drugs, Other Treatments

3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Subsegments:

1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin

2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems

3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy

How Are Trends Influencing The Deep Vein Thrombosis Market?

Product innovations are a significant trend gaining traction in the deep vein thrombosis market. Major companies operating in the deep vein thrombosis market are adopting new technologies to develop novel products and secure their market position. For instance, in January 2023, Penumbra Inc., a US-based developer of innovative therapies, launched Lightning Flash, an advanced and powerful mechanical thrombectomy system designed to address venous and pulmonary thrombus. The system incorporates Penumbra’s distinct lightning-intelligent aspiration technology and innovative dual clot detection algorithms. It is engineered for the rapid removal of large blood clots in the body, including venous thrombus and pulmonary emboli (PE). It provides physicians with a high torque-able, larger catheter crafted for efficiently removing a substantial clot burden in the pulmonary arteries or deep venous system, while upholding an excellent safety profile.

Which Key Market Players Are Investing In Expansion And Innovation Of Deep Vein Thrombosis Market?

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Which Geographies Are Emerging As Strong Markets For The Deep Vein Thrombosis Industry?

North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Deep Vein Thrombosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10616&type=smp

Browse Through More Reports Similar to the Global Deep Vein Thrombosis Market 2025, By The Business Research Company

Blood Culture Tests Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

Blood Collection Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Wearable Blood Pressure Monitors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795